ISOPROPYL MYRISTATE
Molecular Excipient
| Mwt. | LogP | HBD | HBA | PSA | RB | CSP3 |
|---|---|---|---|---|---|---|
| 270.0 | 5.6 | 0 | 2 | 26.0 | 13 | 0.94 |
- CAS
- 110270
- UNII
- 0RE8K4LNJS
- SYNONYMS
-
- ZINC ID(s)
- Availability
- Present in 32 ZINC catalogs
Known Active Genes
There has not been any activity reported at 10μM or less for this excipient (per ChEBML)
Clinical Trials
This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).
(Browse) Purchasable Analogs in ZINC
Dosages
| Route | Formulation | Per Unit Dose |
|---|---|---|
| Auricular (otic) | Suspension | 0.02% |
| Topical | Aerosol | 9.3%W/W |
| Topical | Aerosol, Spray | |
| Topical | Cream, Augmented | 5% |
| Topical | Cream, Emulsion, Sustained Release | 10% |
| Topical | Emulsion, Aerosol Foam | 7.9% |
| Topical | Emulsion, Cream | 15% |
| Topical | Emulsion, Lotion | 1% |
| Topical | Gel | 10%W/W |
| Topical | Lotion | 2% |
| Topical | Oil | |
| Topical | Ointment | 35% |
| Topical | Patch, Controlled Release | |
| Topical | Spray | 31.35% |
| Topical | Suppository | |
| Topical | Suppository, Insert | |
| Transdermal | Film | 58.08MG |
| Transdermal | Film, Controlled Release | |
| Transdermal | Gel | 1% |
| Vaginal | Emulsion, Cream | 5% |